336191-06-1

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 336191-05-0 ethyl (2S)-2-amino-3-({[3-(pyridin-4-yl)-3-azaspiro[5.5]undec-9-yl]carbonyl}amino)propanoate 
• 262290-42-6 (S)-3-amino-2-(toluene-4-sulfonylamino)propionic acid ethyl ester 

Relevant academic research and scientific papers

Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation

Disclosed are certain substituted or unsubstituted pyridyl-containing spirocyclic compounds substituted with both basic and acidic functionality, which are useful in inhibiting platelet aggregation, inhibiting the binding of fibrinogen to blood platelets, and preventing or treating thrombosis

Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 2: Design of potent antagonists containing the 3-azaspiro[5.5]undec-9-yl template

The synthesis and biological activity of novel glycoprotein IIb-IIIa anatagonists containing 3-azaspiro[5.5]undec-9-yl nucleus are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the monoaza